After a month-long clinical hold, Novavax has received the green light from the US Food and Drug Administration (FDA) to resume cl...
Sanofi is now in “exclusive negotiations” with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50...
Recordati has reached an agreement with Sanofi for acquiring the worldwide rights to Enjaymo, the only approved treatment speci...